Adjuvant chemotherapy compared with observation in patients with resected biliary tract cancer: A systematic review and meta-analysis of randomized controlled trials.
<h4>Objectives</h4>Several randomized controlled trials compared adjuvant systemic chemotherapy with observation in patients with resected biliary tract cancer (BTC) have yielded inconsistent outcomes. In order to assess the efficacy of adjuvant therapy in these patients, we conducted th...
Saved in:
| Main Authors: | Liying Tian, Qian Guo, Daidi Fu, Xiao Ma, Linjun Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2025-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0295583 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maintenance chemotherapy in biliary tract tumours in the era of immuno-chemotherapy
by: A. Lamarca, et al.
Published: (2025-03-01) -
Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer Treatment: Insights from the TOPAZ-1 Trial
by: Ralph Fritsch
Published: (2024-10-01) -
Adjuvant Gemcitabine-cisplatin Combination for Biliary Tract Cancer: A Real Life Experience
by: Fatih Kuş, et al.
Published: (2025-08-01) -
Efficacy and safety of combining tislelizumab with capecitabine compared to capecitabine alone in the adjuvant treatment of biliary tract cancers: rationale and protocol design for a randomized clinical trial
by: Xubiao Wei, et al.
Published: (2025-05-01) -
Cost-Effectiveness of Adjuvant Osimertinib With and Without Chemotherapy for Surgically Resected NSCLC
by: Angelos Vasilopoulos, BS, et al.
Published: (2025-06-01)